Hematopoietic Stem Cell Transplant Rates, Utilization of Cord Blood, Awareness Rates, and More
The cord blood banking market has emerged gradually over the past 40 years, as 1974 was the first year in which it was proposed that stem and progenitor cells were present in human cord blood.[1] In the forthcoming years it was established that cord blood stem cells had similar properties as bone marrow and could be used as an alternative. Because it is a rich source of highly primitive hematopoietic stem cells, umbilical cord blood has enormous regenerative potential for stem cell based therapy, both for the treatment of hematological and non-hematological disorders.
[Read more…]